Using inhibitors of PP2A and proteasome function and by monitoring the ubiquitination status of N-Myc, we established that silencing AF1q promotes N-Myc ubiquitination and proteasomal degradation in MYCN amplified neuroblastoma. This evidence concerns the gene MYCN and neuroblastoma.